⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20802097 | 1.00 | — | — | |
| SCHEMBL18545348 | 1.00 | — | — | |
| SCHEMBL9611970 | 1.00 | — | — | |
| SCHEMBL22965652 | 1.00 | — | — | |
| SCHEMBL38019 | 0.88 | — | — | |
| SCHEMBL16134383 | 0.84 | THRB (0.33) | — | |
| SCHEMBL1079117 | 0.84 | THRB (0.33) | — | |
| SCHEMBL16134390 | 0.84 | THRB (0.33) | — | |
| SCHEMBL15579024 | 0.84 | THRB (0.33) | — | |
| SCHEMBL1079119 | 0.84 | THRB (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114585619-B | Alpha-D-galactopyranoside derivatives | 爱杜西亚药品有限公司 | 2024-09-27 | — | — | CN | claimed |
| EP-4021904-A1 | ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | Idorsia Pharmaceuticals Ltd (CH) | 2022-07-06 | — | — | EP | claimed |
| CN-114585619-A | alpha-D-galactopyranoside derivatives | 爱杜西亚药品有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114206893-A | (hetero) aryl-methyl-thio-beta-D-galactopyranoside derivatives | 爱杜西亚药品有限公司 | 2022-03-18 | — | — | CN | claimed |
| EP-2933310-B1 | OCTAHYDRO BINAPHTHYL-BASED CHIRAL COMPOUND-CONTAINING LIQUID-CRYSTAL COMPOSITION AND OPTICAL ELEMENT | JNC CORP (JP) | 2018-06-20 | — | — | EP | claimed |
| CN-114585619-B | Alpha-D-galactopyranoside derivatives | 爱杜西亚药品有限公司 | 2024-09-27 | — | — | CN | disclosed |
| WO-2024086744-A2 | COMPOSITIONS AND USES THEREOF | SOLVE THERAPEUTICS, INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| WO-2024073610-A2 | COMPOSITIONS AND USES THEREOF | SOLVE THERAPEUTICS, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024005460-A1 | COMPOUND COMPRISING SELF-IMMOLATIVE GROUP AND LIGAND-DRUG CONJUGATE COMPRISING SAME | 주식회사 트리오어 | 2024-01-04 | — | — | WO | disclosed |
| WO-2023275715-A1 | METABOLITES OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | PFIZER INC. (US) | 2023-01-05 | — | — | WO | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20220193063-A1 | METABOLITES OF GLP1R AGONISTS | PFIZER INC. (US) | 2022-06-23 | — | — | US | disclosed |
| CN-104854217-B | Liquid-crystal composition, mixture, composite, liquid crystal cell and chipal compounds | 捷恩智株式会社 | 2017-06-23 | — | — | CN | disclosed |
| WO-2017100402-A1 | ONE-POT SYNTHESIS OF ANHYDROPENTITOL ESTERS FROM PENTITOLS, CATALYZED BY WATER-TOLERANT LEWIS ACIDS | ARCHER DANIELS MIDLAND COMPANY (US) | 2017-06-15 | — | — | WO | disclosed |
| CN-106749233-A | One class sulfamide derivative and its application | 中山大学 | 2017-05-31 | — | — | CN | disclosed |
| US-20160161470-A1 | MODULATION OF AXON DEGENERATION | GENENTECH, INC. | 2016-06-09 | — | — | US | disclosed |
| US-9101645-B2 | Modulation of axon degeneration | GENENTECH, INC. (US) | 2015-08-11 | — | — | US | disclosed |
| WO-2015019193-A2 | ACYLATED DERIVATIVES OF PHLORIDZIN AND ISOQUERCETRIN AS ANTICANCER THERAPEUTICS AND METHODS OF USE THEREOF | DALHOUSIE UNIVERSITY (CA) | 2015-02-12 | — | — | WO | disclosed |
| WO-2012044832-A1 | METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS | FETZER OLIVER S (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2011146638-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES | CERULEAN PHARMA INC. (US) | 2011-11-24 | — | — | WO | disclosed |